Not Signed In - UCB Announces Positive Results From Two New Phase III Studies In Rheumatoid Arthritis
Tue, 02 Jan 2007 09:00 AM EST
... UCB today announced positive top-line results for signs and symptoms from two new phase III studies for CIMZIA(TM) (certolizumab pegol), the first Fab' fragment anti-TNF (Tumor Necrosis Factor), in the treatment of rheumatoid arthritis. [click link for full article] ...
Related Topics
- Rheumatoid Arthritis
- Arthritis
- Juvenile Rheumatoid Arthritis
- Rheumatoid Factor
- Rituximab
- Arthritis, Rheumatoid
- Antithrombin III
- Adalimumab
- Septic Arthritis
- Infliximab
- Reactive Arthritis
- Familial Dysautonomia
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Tb
- Etanercept
- Osteoarthritis
- Brain injury that results in physical, emotional, or intellectual changes or deficits
- Autoimmune Diseases
- Congenital antithrombin III deficiency
email this page
print this page
bookmark this page
feedback on this page
